SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-348222
Filing Date
2017-11-20
Accepted
2017-11-20 17:13:03
Documents
7
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 6-K d469009d6k.htm 6-K 17827
2 EX-1.1 d469009dex11.htm EX-1.1 173700
3 EX-5.1 d469009dex51.htm EX-5.1 8577
4 EX-99.1 d469009dex991.htm EX-99.1 9268
5 EX-99.2 d469009dex992.htm EX-99.2 8898
6 GRAPHIC g469009g1120110918036.jpg GRAPHIC 5831
7 GRAPHIC g469009g1120110918239.jpg GRAPHIC 5910
  Complete submission text file 0001193125-17-348222.txt   235732
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 171214570
SIC: 2834 Pharmaceutical Preparations